Clavis Pharma ASA To Present Phase I Clinical Results From ELACYT In Patients With Cancers Of The Bl



 
Clavis Pharma ASA To Present Phase I Clinical Results From ELACYT In Patients With Cancers Of The Bl


Clavis Pharma ASA (OSE: CLAVIS) will present results from the Phase I part of its Phase I/II study with ELACYT, within haematological cancers, at the American Society of Clinical Oncology (ASCO) Annual Meeting 2008, to be held in Chicago on 30 May to 3 June.

read more...

News entry number 5098 added on May 31, 2008 in the Health category.

Comenteaza  

Rating: 0.00 (din 5)
Voturi 0

Adauga Rating


Other News in the Health category
Categorie:

Categorie:

Categorie:

Categorie:

Categorie:


Related Links



News Categories


Top 10 News

Statistics

News:
News Categories:
News Read:
5039
8
622